文献速递临床试验与 GCP真实世界研究与卫生经济

成人专科进食障碍服务中针对神经性厌食症的「阶梯式日间治疗」方案与常规住院治疗方案的临床有效性与成本效果(DAISIES试验):一项随机对照多中心开放标签平行组非劣效性试验的研究方案

The clinical effectiveness and cost-effectiveness of a 'stepping into day treatment' approach versus inpatient treatment as usual for anorexia nervosa in adult specialist eating disorder services (DAISIES trial): a study protocol of a randomised controlled multi-centre open-label parallel group non-inferiority trial.
PubMed 文献 · Trials · 2022-06-16

DAISIES试验为一项两臂多中心开放标签平行组非劣效性随机对照试验,计划纳入386例需强化治疗的成人严重神经性厌食症患者(BMI≤16 kg/m2),随机分配至常规住院治疗或阶梯式日间治疗,主要结局为随机化后12个月时BMI,旨在评估阶梯式日间治疗是否非劣效于常规住院治疗并比较成本效果。

要点

  • 计划纳入386例成人严重神经性厌食症患者(BMI≤16 kg/m2),随机分为常规住院治疗组与阶梯式日间治疗组。
  • 主要结局为随机化后12个月时BMI,用于判断阶梯式日间治疗是否非劣效于常规住院治疗。
  • 两组均治疗至达到健康体重或尽可能接近该目标,并在基线、6个月和12个月进行评估。

核心结论

  • 本试验旨在确定在成人严重神经性厌食症中,阶梯式日间治疗方案在改善随机化后12个月时BMI方面是否非劣效于常规住院治疗。
  • 研究结果将为两种强化治疗方案提供严格评估,并为未来国家和国际治疗指南及服务提供提供依据。

研究设计与样本

  • 两臂多中心开放标签平行组非劣效性随机对照试验,计划纳入386例符合《精神障碍诊断与统计手册》第五版严重神经性厌食症或相关障碍诊断、BMI≤16 kg/m2且需要强化治疗的患者。
  • 患者随机分配至常规住院治疗或阶梯式日间治疗方案(日间治疗联合初始住院治疗以进行医学稳定化的选项)。

主要发现

  • 两组患者均接受治疗直至达到健康体重或尽可能接近该目标。
  • 评估在基线(随机化前)以及随机化后6个月和12个月进行,并额外进行每月症状监测。
  • 主要结局为随机化后12个月评估时的BMI。
  • 其他结局包括心理社会适应、治疗动机、期望与体验、成本效果以及照护者负担。

关键数值与推荐

  • 纳入标准为《精神障碍诊断与统计手册》第五版严重神经性厌食症或相关障碍诊断、BMI≤16 kg/m2且需要强化治疗。
  • 主要结局为随机化后12个月时的BMI。
  • 试验注册号为ISRCTN10166784,注册日期为2020年2月28日。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anorexia nervosa (AN) is a serious and disabling mental disorder with a high disease burden. In a proportion of cases, intensive hospital-based treatments, i.e. inpatient or day patient treatment, are required, with day patient treatment often being used as a 'step-down' treatment after a period of inpatient treatment. Demand for such treatment approaches has seen a sharp rise. Despite this, the relative merits of these approaches for patients, their families, and the NHS and wider society are relatively unknown. This paper describes the rationale for, and protocol of, a two-arm multi-centre open-label parallel group non-inferiority randomised controlled trial, evaluating the effectiveness and cost-effectiveness of these two intensive treatments for adults with severe AN: inpatient treatment as usual and a stepped care day patient approach (the combination of day patient treatment with the option of initial inpatient treatment for medical stabilisation). The main aim of this trial is to establish whether, in adults with severe AN, a stepped care day patient approach is non-inferior to inpatient treatment as usual in relation to improving body mass index (BMI) at 12 months post-randomisation. METHODS: 386 patients with a Diagnostic and Statistical Manual 5th edition diagnosis of severe AN or related disorder, with a BMI of ≤16 kg/m2 and in need of intensive treatment will be randomly allocated to either inpatient treatment as usual or a stepped care day patient approach. Patients in both groups will receive treatment until they reach a healthy weight or get as close to this point as possible. Assessments will be conducted at baseline (prior to randomisation), and at 6 and 12 months post-randomisation, with additional monthly symptom monitoring. The primary outcome will be BMI at the 12-month post-randomisation assessment. Other outcomes will include psychosocial adjustment; treatment motivation, expectations and experiences; cost-effectiveness; and carer burden. DISCUSSION: The results of this study will provide a rigorous evaluation of two intensive treatment approaches which will inform future national and international treatment guidelines and service provision. TRIAL REGISTRATION: ISRCTN ISRCTN10166784 . Registered 28 February 2020. ISRCTN is a primary registry of the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) network and includes all items from the WHO Trial Registration Data Set.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Irish M, Dalton B, Potts L, et al. The clinical effectiveness and cost-effectiveness of a 'stepping into day treatment' approach versus inpatient treatment as usual for anorexia nervosa in adult specialist eating disorder services (DAISIES trial): a study protocol of a randomised controlled multi-centre open-label parallel group non-inferiority trial. Trials. 2022. PMID: 35710394. doi:10.1186/s13063-022-06386-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。